Why Is My Hair Shedding at 40? Causes, Blood Tests & What Helps

The short answer: hair shedding around 40 is common, but perimenopause is not the only explanation and a blood test is not always the first step. The most useful first distinction is whether you have sudden diffuse shedding or progressive thinning and a widening part. Sudden shedding often points toward telogen effluvium after illness, weight loss, stress, childbirth, medication change or nutritional deficiency. Progressive central thinning raises the possibility of female-pattern hair loss, which becomes more common with age and around the menopausal transition. Iron deficiency and thyroid disease can contribute; low vitamin D is associated with several forms of alopecia, although supplementation only makes sense when deficiency is present. The right treatment depends on the pattern and cause.

“Why is my hair shedding at 40?” sounds like one question, but clinically it is several different questions hiding inside the same symptom.

At 40, hair can become more noticeable in the shower because the follicle cycle has temporarily shifted. Or the ponytail can slowly become smaller because individual follicles are miniaturising. Those two processes can happen at the same time — but they are not treated the same way.

Hair shedding vs hair thinning: first identify which one you have

What you notice	More suggestive of	Typical clue
Suddenly much more hair in the shower or brush	Telogen effluvium	Often begins 2–3 months after a trigger
Gradually widening central part	Female-pattern hair loss	Progressive reduction in density and hair calibre
Both shedding and a widening part	Telogen effluvium + underlying female-pattern hair loss	A temporary shed can expose previously subtle miniaturisation
Round or sharply defined bald patches	Alopecia areata or another focal disorder	Not typical of ordinary perimenopausal shedding
Hairline recession with scalp redness, scale, pain or loss of follicle openings	Possible scarring alopecia	Needs prompt dermatologic assessment

This distinction matters more than immediately buying a supplement because the same visible complaint — “I am losing hair” — can represent very different follicle biology.

1. Perimenopause can change the hair cycle — but it is not the whole diagnosis

The menopausal transition can begin years before the final menstrual period. During this period, estrogen fluctuates and eventually declines, while the relative hormonal environment around the follicle also changes.

A 2025 review in Maturitas describes the hair follicle as an estrogen-sensitive tissue and notes that the menopausal transition can be associated with reduced density, reduced fibre calibre and changes in hair texture. Female-pattern hair loss, telogen effluvium and frontal fibrosing alopecia are all seen more often in postmenopausal women.

That does not mean every woman who sheds at 40 is simply “losing estrogen.”

If you also have irregular periods, hot flushes, sleep disruption or other perimenopausal symptoms, the hormonal transition may be part of the context. But a widening part, persistent miniaturisation or a sudden heavy shed still deserves its own diagnosis.

At 40, hormones can change the terrain. They do not tell you automatically which hair-loss disorder is present.

2. Female-pattern hair loss often becomes visible in this decade

Female-pattern hair loss (FPHL), also called female androgenetic alopecia, is the most common progressive hair-loss disorder in women.

Instead of a dramatic shed, many women first notice:

• a widening centre part;
• less volume at the crown;
• a smaller ponytail;
• more scalp showing under overhead light;
• and increasingly fine hairs in the affected area.

The biology involves progressive follicular miniaturisation and shortening of the active growth phase. A 2026 clinical review emphasizes that female-pattern hair loss is underdiagnosed and that hormonal, genetic and environmental factors interact in its development.

Importantly, the often-repeated statistic that “40% of women have hair loss by 50” is not universal. Prevalence varies by population and diagnostic criteria. A recent clinical summary estimates detectable FPHL in about 25% of women by age 50, while older studies report substantially different rates across Caucasian and Asian populations.

That matters for SKINĒDIT’s Asian audience: historical population studies in China, Korea and Taiwan generally reported lower age-specific prevalence than many Western cohorts. So a single “40% by 50” statistic should not be presented as a biological rule for every woman.

3. Telogen effluvium: look 2–3 months backwards

If the shedding appeared suddenly, think backwards.

Telogen effluvium is a diffuse shed that commonly becomes noticeable around two to three months after a physiological or psychological trigger.

Common triggers include:

• high fever or significant illness;
• surgery;
• rapid weight loss or crash dieting;
• childbirth;
• major psychological stress;
• some medication changes;
• and nutritional deficiency.

The time delay is one of the best clues. What happened in June can show up as shedding in August or September.

When the trigger is temporary and the follicle is otherwise healthy, telogen effluvium often improves after the cause resolves. But a major shed can also reveal underlying FPHL that had previously been difficult to see.

4. Iron deficiency: important to check when the history fits, but there is no magic ferritin number for hair

Iron is required for normal cellular function, and iron deficiency can coexist with diffuse hair shedding — particularly in menstruating women, people with heavy periods, restrictive diets or recent blood loss.

Recent studies continue to find lower ferritin levels in groups of women with telogen effluvium. But the literature is not perfectly consistent: a large controlled study found that iron deficiency was common in women generally and was not significantly more frequent in women with FPHL or chronic telogen effluvium than in controls.

This is why the popular advice that “your ferritin must be above 40, 50 or 70 for hair growth” is too simplistic. There is no universally accepted hair-specific ferritin target.

If the history suggests iron deficiency, a clinician may check:

• complete blood count;
• serum ferritin;
• and, where appropriate, additional iron studies.

Do not take high-dose iron simply because your hair is shedding. Correct documented deficiency rather than guessing.

5. Thyroid dysfunction can cause diffuse shedding

Both hypothyroidism and hyperthyroidism can alter the hair cycle and cause diffuse loss.

Thyroid testing becomes particularly relevant when shedding is unexplained or accompanied by symptoms such as:

• unusual fatigue;
• heat or cold intolerance;
• unexplained weight change;
• palpitations;
• constipation;
• tremor;
• or menstrual changes.

A TSH test is commonly part of the investigation when thyroid disease is plausible.

But again, not every 40-year-old woman with hair shedding needs an indiscriminate panel of blood tests. History and scalp pattern should determine what is worth testing.

6. Vitamin D: association is real; the treatment question is more complicated

Vitamin-D deficiency is frequently reported in women with hair-loss disorders.

A 2024 meta-analysis found vitamin-D deficiency in substantial proportions of patients with female-pattern hair loss and telogen effluvium, and another systematic review incorporating studies through September 2024 found similar associations across several alopecias.

However, an association does not prove that vitamin-D supplementation will regrow hair in every woman with shedding.

The practical position is straightforward: if you are deficient, correct the deficiency for general health and because adequate nutritional status matters to the follicle. Do not treat vitamin D as a universal hair-growth drug.

7. Weight loss, low protein and restrictive dieting can trigger a shed

The early 40s are also a common time for aggressive dieting, GLP-1-associated weight change and major shifts in eating patterns.

Hair follicles are metabolically active. Rapid weight loss, low energy intake and inadequate protein can act as physiological stressors and precipitate telogen effluvium.

If the shedding began several months after a large or rapid weight change, that timeline is worth discussing with your clinician.

The answer is not automatically a “hair vitamin.” The first task is making sure the body is no longer receiving a metabolic signal that favours shedding.

8. Stress can cause shedding — but “stress” should not become the diagnosis of last resort

Major psychological or physical stress can trigger telogen effluvium. But hair loss is too often dismissed as stress before the scalp pattern, medications, diet, iron status, thyroid history and possibility of FPHL have been considered.

If the shedding is persistent, progressive or accompanied by visible miniaturisation, do not stop the investigation at “you are stressed.”

What blood tests should a woman with hair shedding ask for?

There is no single mandatory “hair-loss blood panel.” Testing should follow the history.

Test	When it may be useful
CBC + ferritin	Heavy menstrual bleeding, vegetarian/restrictive diet, fatigue, recent blood loss, diffuse unexplained shedding
TSH	Unexplained diffuse shedding or symptoms/risk factors for thyroid dysfunction
25-OH vitamin D	Risk factors or suspected deficiency; useful in selected diffuse hair-loss work-ups
B12 / folate / zinc	Usually targeted to diet, malabsorption, symptoms or specific deficiency risk rather than ordered automatically
Androgen / endocrine testing	When hair loss occurs with hirsutism, severe adult acne, irregular cycles or other signs of hyperandrogenism

The smartest first move is therefore not always “get blood work.” It is identify the pattern, review the preceding months, then order the tests that could realistically change what you do next.

What actually works for hair thinning at 40?

Treatment depends on the diagnosis.

If it is telogen effluvium

Find and remove the trigger where possible: correct deficiency, stabilize nutrition, review medications with the prescribing clinician, and allow the hair cycle time to recover.

If it is female-pattern hair loss

Topical minoxidil remains the only FDA-approved treatment for female-pattern hair loss in the United States and has a much stronger evidence base than nutritional supplements for follicular miniaturisation.

Dermatologists may also use other therapies — including oral minoxidil or antiandrogen strategies — in selected women, but these have different safety considerations and should be medically supervised.

If it is a deficiency

Correct the actual deficiency. Iron deficiency gets iron. Vitamin-D deficiency gets vitamin D. A biotin megadose does not substitute for either.

For the evidence on biotin specifically, see does biotin work for hair growth?

Does hormone therapy stop menopausal hair loss?

This is an important question, but the evidence is not strong enough to treat menopausal hormone therapy as a dedicated hair-loss treatment.

A 2026 systematic review specifically examined estrogen therapy and menopausal hair loss, reflecting growing interest in the subject. But hair response is not currently a reason to start menopausal hormone therapy on its own.

MHT decisions should be based on the broader menopausal risk–benefit discussion with a clinician, not on a supplement or hair article promising that replacing estrogen will restore density.

THE ROOT RESPONSE

REVIVAL

Signal · Anchor · Fibre

REVIVAL approaches ongoing thinning through follicular signalling, anchoring and hair-fibre biology. It is designed as nutritional follicle support — not as a substitute for diagnosing iron deficiency, thyroid disease, telogen effluvium or female-pattern hair loss.

Explore the REVIVAL architecture →

Where a hair supplement fits — and where it does not

A supplement can make sense as one layer of a hair strategy, but it should not be asked to do the job of diagnosis.

A useful formula should be judged on:

• defined ingredients rather than generic “hair vitamins”;
• human evidence relevant to the hair outcome claimed;
• realistic timelines;
• and a clear distinction between nutritional support and treatment of a medical hair-loss disorder.

REVIVAL is built around this distinction. One of the hair ingredients within its architecture, Cynatine® HNS, has been studied as a defined keratin-based complex in a randomized, double-blind, placebo-controlled 90-day study. The study reported improvements in hair-pull measures, anagen/telogen ratio and hair-strength outcomes relative to placebo.

That is ingredient-level evidence. It does not mean finished REVIVAL has been clinically proven to treat female-pattern hair loss, perimenopausal alopecia or telogen effluvium.

How can you tell if shedding is becoming female-pattern hair loss?

Look at the pattern over time, not only the number of hairs in the drain.

More suspicious for FPHL:

• a steadily widening part;
• reduced density over the crown;
• progressively finer hairs;
• loss that continues even after a temporary shedding episode ends;
• and a family history of pattern hair loss.

A dermatologist can use scalp examination and trichoscopy to look for follicular miniaturisation and distinguish FPHL from telogen effluvium more accurately than counting shed hairs at home.

When should you see a dermatologist?

Seek assessment rather than experimenting with supplements indefinitely if:

• the shedding is severe or persists for more than several months;
• your centre part is progressively widening;
• you have discrete bald patches;
• the scalp is painful, red, scaly or scarred;
• the frontal hairline is receding;
• you have hirsutism, severe acne or very irregular cycles;
• you have symptoms suggesting iron or thyroid disease;
• or you are losing eyebrow or body hair as well.

Earlier diagnosis matters most when the problem is progressive miniaturisation or a scarring disorder, because those are not simply temporary shedding.

Frequently asked questions

Why is my hair suddenly shedding at 40?

Sudden diffuse shedding is often telogen effluvium, which commonly appears two to three months after a trigger such as illness, rapid weight loss, childbirth, major stress, medication change or nutritional deficiency. Perimenopause can change the hair environment, but it is not the only possible cause.

Can perimenopause cause hair shedding?

Yes. The hair follicle is estrogen-sensitive, and the menopausal transition can be associated with changes in density, fibre calibre and hair cycling. But persistent thinning at the crown or a widening part may indicate female-pattern hair loss rather than hormonal shedding alone.

How can I tell hair shedding from female-pattern hair loss?

Telogen effluvium usually causes a relatively sudden increase in diffuse shedding. Female-pattern hair loss is typically gradual and produces central scalp thinning, widening of the part and progressive follicular miniaturisation. The two can coexist.

What blood tests should I get for hair loss at 40?

Testing should be targeted. CBC and ferritin may be useful when iron deficiency is plausible; TSH when thyroid disease is possible; and vitamin D when deficiency risk exists. Other tests depend on diet, symptoms and signs of hormonal disease. There is no universal hair-loss blood panel for every woman.

What ferritin level is needed for hair growth?

There is no universally accepted hair-specific ferritin target. Very low ferritin indicates depleted iron stores, but fixed claims that every woman needs ferritin above 40, 50 or 70 ng/mL for hair growth are not firmly established by clinical evidence.

Can low vitamin D cause hair loss?

Vitamin-D deficiency is associated with several non-scarring hair-loss disorders in meta-analyses. That association does not prove vitamin D supplementation regrows hair in everyone. Correct a documented deficiency rather than treating vitamin D as a universal hair-growth drug.

Does thyroid disease cause hair shedding?

Yes. Both underactive and overactive thyroid states can contribute to diffuse hair loss. Thyroid testing is particularly useful when shedding is unexplained or accompanied by symptoms of thyroid dysfunction.

Does biotin help hair shedding at 40?

Usually not unless a true biotin deficiency exists. Current systematic reviews do not support routine high-dose biotin for hair loss in people without documented deficiency.

What actually works for female-pattern hair loss?

Topical minoxidil remains the only FDA-approved treatment for female-pattern hair loss in the United States. Other prescription options may be considered by dermatologists depending on age, hormonal context, medical history and contraindications.

Will hair shedding at 40 grow back?

Telogen effluvium often recovers after the trigger resolves. Female-pattern hair loss is progressive and generally requires ongoing management rather than waiting for spontaneous recovery. Correct diagnosis determines the prognosis.

Which SKINĒDIT Protocol is for women’s hair thinning?

REVIVAL is the SKINĒDIT Protocol for ongoing thinning and density support. It is designed around follicular signalling, anchoring and hair-fibre biology, and should complement rather than replace investigation of unexplained or progressive hair loss.

Related reading

• Best supplement for women’s hair thinning
• Does biotin work for hair growth?
• Menopause hair loss: what helps?
• Postpartum hair loss: when it starts, peaks and stops

References

Gupta AK, Economopoulos V, Mann A, Wang T, Mirmirani P. Menopause and hair loss in women: exploring the hormonal transition. Maturitas. 2025;198:108378.

Kearney CA, Brinks AL, Lawrence CN, et al. Androgenetic alopecia in women: a narrative review of pathophysiology, clinical evaluation, and treatments. American Journal of Clinical Dermatology. 2026;27(2):363–389.

Female pattern hair loss. CMAJ. 2026.

Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. Journal of the American Academy of Dermatology. 2010.

Moeinvaziri M, Mansoori P, Holakooee K, Safaee Naraghi Z, Abbasi A. Iron status in diffuse telogen hair loss among women. Acta Dermatovenerologica Croatica. 2009.

Thamotharan S, et al. Assessment of serum ferritin levels in female patients with telogen effluvium. 2025.

Chen Y, Dong X, Wang Y, et al. Serum 25 hydroxyvitamin D in non-scarring alopecia: a systematic review and meta-analysis. Journal of Cosmetic Dermatology. 2024;23(4):1131–1140.

Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis. 2024.

Farkas E, Nehorayan I, Hanan R, et al. Untangling estrogen therapy for menopausal hair loss: a systematic review. Journal of the American Academy of Dermatology. 2026.

Beer C, Wood S, Veghte RH. A clinical trial to investigate the effect of Cynatine HNS on hair and nail parameters. The Scientific World Journal. 2014;2014:641723.

Evidence note: hair shedding, telogen effluvium and female-pattern hair loss are different clinical entities and can coexist. Nutrient associations do not prove that supplementation benefits people without deficiency. REVIVAL is nutritional follicle support and is not claimed to diagnose or treat iron deficiency, thyroid disease, female-pattern hair loss or other medical alopecias. Persistent, progressive, patchy or scarring hair loss should be evaluated by a qualified clinician.